Scholars@Duke

• Background
• 

  Education, Training, & Certifications

  • M.D., University of Michigan, Ann Arbor 2013
• 

  Previous Appointments & Affiliations

  • Assistant Professor of Dermatology, Dermatology, Clinical Science Departments 2021 - 2023
  • Assistant Professor of Dermatology, Dermatology, Clinical Science Departments 2017 - 2020
• 

  Leadership & Clinical Positions at Duke

  • Managing Director - Dermatology Clinical Research Unit
    
    Medical Director - Teledermatology Service
    
    
    
• Research
• 

  Selected Grants

  • A Phase 2, Multi-Center Study Evaluating the Safety and Efficacy of ENV-101 (Taladegib) in Patients with Advanced Solid Tumors Harboring PTCH1 Loss ofFunction Mutations awarded by Endeavor BioMedicines, Inc. 2023 - 2026
  • A Study to Support Next Generation Sequencing Screening Process of Endeavor Studies in Patients with Advanced Solid Tumors awarded by Endeavor BioMedicines, Inc. 2023 - 2026
  • To assess the safety and tolerability of single agent RP1 in selected organ transplant recipients awarded by Replimune Group, INC 2021 - 2025
  • An Open-Label Single-Arm Study of Dupilumab in Adolescent and Adult Skin of Color Patients with Moderate-to-Severe Atopic Dermatitis awarded by Regeneron Pharmaceuticals, Inc. 2023 - 2025
  • A Phase 1 Study of Pre-Operative Cemiplimab (REGN2810), Administered Intralesionally, for Patients with Recurrent Cutaneous Squamous Cell Carcinoma (CSCC) awarded by Regeneron Pharmaceuticals, Inc. 2019 - 2024
  • A MULTICENTER, PHASE 2B, RANDOMIZED, DOUBLE-BLIND, STRATIFIED, VEHICLE-CONTROLLED STUDY EVALUATING THE SAFETY AND EFFICACY OF SIROLIMUS 3.9% TOPICAL GEL IN PREVENTION OF BCCS IN PATIENTS WITH GORLIN SYNDROME awarded by Palvella Therapeutics, Inc 2021 - 2023
  • A Multicenter, Randomized, Double blind, Vehicle-controlled, Phase 2 Efficacy and Safety Study of Patidegib Topical Gel, 2%, for the Reduction of Disease Burden of Persistently Developing Basal Cell C awarded by PellePharm 2020 - 2022
  • Pelle-926-301E: A Phase 3, Multicenter, Open-Label Extension Study of Patidegib Topical Gel, 2% in Subjects with Gorlin Syndrome (Basal Cell Nevus Syndrome) awarded by PellePharm 2020 - 2021
  • A Multicenter, Randomized, Double-blind, Vehicle-controlled, Phase 3 Efficacy and Safety Study of Patidegib Topical Gel, 2%, for the Reduction of Disease Burden of Persistently Developing Basal Cell C awarded by PellePharm 2019 - 2021
  • Qualification of the Methodology to Identify and Measure Basal Cell Carcinomas (BCCs) on the face of patients with Basal Cell Nevus Syndrome (Gorlin Syndrome) or Sporadic BCCs awarded by PellePharm 2018 - 2020
• 

  External Relationships

  • Department of Justice
  • Dermotech, LLC
  • Regeneron Pharmaceuticals
  • Skintelligent
  • Spectrum Pharmaceuticals Inc.
  • Sun Pharmaceuticals
• Publications & Artistic Works
• 

  Selected Publications

  • Academic Articles

    • Kashani-Sabet, Mohammed, Sancy A. Leachman, Jennifer A. Stein, Jack L. Arbiser, Elizabeth G. Berry, Julide T. Celebi, Clara Curiel-Lewandrowski, et al. “Early Detection and Prognostic Assessment of Cutaneous Melanoma: Consensus on Optimal Practice and the Role of Gene Expression Profile Testing.” Jama Dermatol 159, no. 5 (May 1, 2023): 545–53. https://doi.org/10.1001/jamadermatol.2023.0127.
       Full Text  Link to Item
    • Patel, Akash D., Chandler W. Rundle, Beiyu Liu, Cynthia L. Green, Christian L. Bailey-Burke, and Meenal Kheterpal. “Teledermatology May Benefit Marginalized Populations: National and Institutional Trends during the COVID-19 Pandemic.” Dermatol Ther (Heidelb) 13, no. 3 (March 2023): 827–34. https://doi.org/10.1007/s13555-023-00900-8.
       Full Text  Link to Item
    • Kheterpal, Meenal, Ethan D. Borre, Matilda W. Nicholas, Edward W. Cooner, Donna Phinney, Kelly Gagnon, Leah L. Zullig, Heather A. King, Elizabeth J. Malcolm, and Suephy C. Chen. “Implementation Evaluation of a Teledermatology Virtual Clinic at an Academic Medical Center.” Res Sq, February 28, 2023. https://doi.org/10.21203/rs.3.rs-2558425/v1.
       Full Text  Link to Item
    • Jeong, Hyeon Ki, Christine Park, Ricardo Henao, and Meenal Kheterpal. “Deep Learning in Dermatology: A Systematic Review of Current Approaches, Outcomes, and Limitations.” Jid Innov 3, no. 1 (January 2023): 100150. https://doi.org/10.1016/j.xjidi.2022.100150.
       Full Text  Link to Item
    • Fixsen, Emma, Jigar Patel, and Meenal Kheterpal. “Atypical Localized Scleroderma Development During Nivolumab Therapy for Metastatic Lung Adenocarcinoma.” Cutis 110, no. 4 (October 2022): E11–13. https://doi.org/10.12788/cutis.0637.
       Full Text  Link to Item
    • Xia, Meng, Meenal K. Kheterpal, Samantha C. Wong, Christine Park, William Ratliff, Lawrence Carin, and Ricardo Henao. “Lesion identification and malignancy prediction from clinical dermatological images.” Sci Rep 12, no. 1 (September 23, 2022): 15836. https://doi.org/10.1038/s41598-022-20168-w.
       Full Text  Link to Item
    • Schlessinger, Daniel I., Kelly A. Reynolds, McKenzie A. Dirr, Sarah A. Ibrahim, Arianna F. Yanes, Jake M. Lazaroff, Victoria Godinez-Puig, et al. “Development of a core outcome set for basal cell carcinoma.” J Am Acad Dermatol 87, no. 3 (September 2022): 573–81. https://doi.org/10.1016/j.jaad.2022.04.059.
       Full Text  Link to Item
    • Penny, Caitlin L., Krystina Quow, Chandler W. Rundle, Rami N. Al-Rohil, Adela R. Cardones, Meenal K. Kheterpal, and Amber I. Fresco. “Response to 'Clinical and direct immunofluorescence characteristics of cutaneous toxicity associated with enfortumab vedotin': reply from the authors.” Br J Dermatol 187, no. 2 (August 2022): 275–76. https://doi.org/10.1111/bjd.21239.
       Full Text  Link to Item
    • Penny, Caitlin L., Krystina Quow, Chandler W. Rundle, Rami N. Al-Rohil, Adela R. Cardones, Meenal K. Kheterpal, and Amber I. Fresco. “Clinical and direct immunofluorescence characteristics of cutaneous toxicity associated with enfortumab vedotin.” Br J Dermatol 187, no. 1 (July 2022): 126–27. https://doi.org/10.1111/bjd.21022.
       Full Text  Link to Item
    • Penny, Caitlin, Neel Nath, and Meenal Kheterpal. “Successful Outpatient Management of Diffuse Photosensitive Bullous Dermatitis Following Pembrolizumab Therapy.” J Drugs Dermatol 21, no. 6 (June 1, 2022): 668–70. https://doi.org/10.36849/JDD.6715.
       Full Text  Link to Item
    • Park, C., H. K. Jeong, R. Henao, and M. Kheterpal. “Current Landscape of Generative Adversarial Networks for Facial Deidentification in Dermatology: Systematic Review and Evaluation.” Jmir Dermatology 5, no. 2 (May 1, 2022). https://doi.org/10.2196/35497.
       Full Text
    • Patel, Akash D., Surya Ravichandran, and Meenal Kheterpal. “Hedgehog inhibitors with and without adjunctive therapy in treatment of locally advanced basal cell carcinoma.” Int J Dermatol 61, no. 1 (January 2022): 118–24. https://doi.org/10.1111/ijd.15836.
       Full Text  Link to Item
    • Wong, Samantha C., William Ratliff, Meng Xia, Christine Park, Mark Sendak, Suresh Balu, Ricardo Henao, Lawrence Carin, and Meenal K. Kheterpal. “Use of convolutional neural networks in skin lesion analysis using real world image and non-image data.” Front Med (Lausanne) 9 (2022): 946937. https://doi.org/10.3389/fmed.2022.946937.
       Full Text  Link to Item
    • Borre, Ethan D., Suephy C. Chen, Matilda W. Nicholas, Edward W. Cooner, Donna Phinney, Amanda Morrison, Natalie Combs, and Meenal Kheterpal. “Early Implementation and Evaluation of a Teledermatology Virtual Clinic Within an Academic Medical Center.” Iproceedings 6, no. 1 (December 20, 2021): e35432–e35432. https://doi.org/10.2196/35432.
       Full Text
    • Jeong, Hyeon Ki, Christine Park, Ricardo Henao, and Meenal Kheterpal. “Privacy Protection With Facial Deidentification Machine Learning Methods: Can Current Methods Be Applied to Dermatology?” Iproceedings 6, no. 1 (December 17, 2021): e35431–e35431. https://doi.org/10.2196/35431.
       Full Text
    • Borre, Ethan D., Suephy C. Chen, Matilda W. Nicholas, Edward W. Cooner, Donna Phinney, Amanda Morrison, Natalie Combs, and Meenal Kheterpal. “Early Implementation and Evaluation of a Teledermatology Virtual Clinic Within an Academic Medical Center (Preprint),” December 3, 2021. https://doi.org/10.2196/preprints.35432.
       Full Text
    • Jeong, Hyeon Ki, Christine Park, Ricardo Henao, and Meenal Kheterpal. “Privacy Protection With Facial Deidentification Machine Learning Methods: Can Current Methods Be Applied to Dermatology? (Preprint),” December 3, 2021. https://doi.org/10.2196/preprints.35431.
       Full Text
    • Patel, Arsh, Jane S. Kim, Jason Liss, Lauren Howard, Sin-Ho Jung, and Meenal Kheterpal. “Outcomes of adjunctive therapies post hedgehog inhibitors in the management of locally advanced basal cell carcinoma: A systematic review and pooled analysis.” Dermatologic Therapy 34, no. 6 (November 2021): e15172. https://doi.org/10.1111/dth.15172.
       Full Text
    • Gutzmer, Ralf, Carmen Loquai, Caroline Robert, Brigitte Dréno, Alexander Guminski, Karl Lewis, Ramon Arntz, Serena Martelli, Nicholas Squittieri, and Meenal Kheterpal. “Key Clinical Adverse Events in Patients with Advanced Basal Cell Carcinoma Treated with Sonidegib or Vismodegib: A Post Hoc Analysis.” Dermatol Ther (Heidelb) 11, no. 5 (October 2021): 1839–49. https://doi.org/10.1007/s13555-021-00588-8.
       Full Text  Link to Item
    • Leckey, Bruce D., Meenal K. Kheterpal, M Angelica Selim, and Rami N. Al-Rohil. “Cutaneous involvement by T-cell prolymphocytic leukemia presenting as livedoid vasculopathy.” J Cutan Pathol 48, no. 7 (July 2021): 975–79. https://doi.org/10.1111/cup.14023.
       Full Text  Link to Item
    • Xia, Meng, Meenal K. Kheterpal, Samantha C. Wong, Christine Park, William Ratliff, Lawrence Carin, and Ricardo Henao. “Malignancy Prediction and Lesion Identification from Clinical Dermatological Images,” April 2, 2021.
       Open Access Copy  Link to Item
    • Ravichandran, Surya, and Meenal K. Kheterpal. “Apremilast for the off-label treatment of lichenoid and interface dermatoses.” J Am Acad Dermatol 83, no. 5 (November 2020): 1489–91. https://doi.org/10.1016/j.jaad.2020.05.112.
       Full Text  Link to Item
    • Kheterpal, Meenal K., Julia Dai, Shamir Geller, Melissa Pulitzer, Andy Ni, Patricia L. Myskowski, Alison Moskowitz, et al. “Role of imaging in low-grade cutaneous B-cell lymphoma presenting in the skin.” J Am Acad Dermatol 81, no. 4 (October 2019): 970–76. https://doi.org/10.1016/j.jaad.2019.01.037.
       Full Text  Link to Item
    • Kelsey, Chris R., Endi Wang, Alexandra Stefanovic, and Meenal Kheterpal. “Radiation therapy for primary cutaneous γδ T-cell lymphoma: Case report and literature review.” Jaad Case Rep 5, no. 7 (July 2019): 582–86. https://doi.org/10.1016/j.jdcr.2019.05.002.
       Full Text  Open Access Copy  Link to Item
    • Fixsen, Emma, Jigar Patel, Maria Angelica Selim, and Meenal Kheterpal. “Resolution of Pembrolizumab-Associated Steroid-Refractory Lichenoid Dermatitis with Cyclosporine.” Oncologist 24, no. 3 (March 2019): e103–5. https://doi.org/10.1634/theoncologist.2018-0531.
       Full Text  Link to Item
    • Quaglino, P., M. Maule, H. M. Prince, P. Porcu, S. Horwitz, M. Duvic, R. Talpur, et al. “Global patterns of care in advanced stage mycosis fungoides/Sezary syndrome: a multicenter retrospective follow-up study from the Cutaneous Lymphoma International Consortium.” Ann Oncol 30, no. 3 (March 1, 2019): 494. https://doi.org/10.1093/annonc/mdy207.
       Full Text  Link to Item
    • Lebowitz, E., S. Geller, E. Flores, M. Pulitzer, S. Horwitz, A. Moskowitz, M. Kheterpal, and P. L. Myskowski. “Survival, disease progression and prognostic factors in elderly patients with mycosis fungoides and Sézary syndrome: a retrospective analysis of 174 patients.” J Eur Acad Dermatol Venereol 33, no. 1 (January 2019): 108–14. https://doi.org/10.1111/jdv.15236.
       Full Text  Link to Item
    • Geller, Shamir, Melissa Pulitzer, Patricia Myskowski, and Meenal Kheterpal. “Low-Grade Cutaneous B-cell Lymphoma in African American Patients.” J Drugs Dermatol 17, no. 12 (December 1, 2018): 1334–37.
       Link to Item
    • Pulitzer, Melissa, Shamir Geller, Erica Kumar, Denise Frosina, Alison Moskowitz, Steven Horwitz, Patricia Myskowski, et al. “T-cell receptor-δ expression and γδ+ T-cell infiltrates in primary cutaneous γδ T-cell lymphoma and other cutaneous T-cell lymphoproliferative disorders.” Histopathology 73, no. 4 (October 2018): 653–62. https://doi.org/10.1111/his.13671.
       Full Text  Link to Item
    • Geller, Shamir, Haoming Xu, Mark Lebwohl, Beatrice Nardone, Mario E. Lacouture, and Meenal Kheterpal. “Malignancy Risk and Recurrence with Psoriasis and its Treatments: A Concise Update.” Am J Clin Dermatol 19, no. 3 (June 2018): 363–75. https://doi.org/10.1007/s40257-017-0337-2.
       Full Text  Link to Item
    • Warren, Shay, Meenal Kheterpal, Patricia L. Myskowski, Alison Moskowitz, Steven M. Horwitz, and Melissa P. Pulitzer. “Unrelated immunodeficiency states may impact outcomes and immune checkpoint molecule expression in patients with mycosis fungoides: A clinicopathologic case-control study.” J Am Acad Dermatol 78, no. 3 (March 2018): 530–39. https://doi.org/10.1016/j.jaad.2017.09.015.
       Full Text  Link to Item
    • Quaglino, P., M. Maule, H. M. Prince, P. Porcu, S. Horwitz, M. Duvic, R. Talpur, et al. “Global patterns of care in advanced stage mycosis fungoides/Sezary syndrome: a multicenter retrospective follow-up study from the Cutaneous Lymphoma International Consortium.” Ann Oncol 28, no. 10 (October 1, 2017): 2517–25. https://doi.org/10.1093/annonc/mdx352.
       Full Text  Link to Item
    • Georgesen, Corey, Meenal Kheterpal, and Melissa Pulitzer. “A Rare Case of Cutaneous Plasmacytosis in a Korean Male.” Case Rep Pathol 2017 (2017): 3032941. https://doi.org/10.1155/2017/3032941.
       Full Text  Link to Item
    • Kheterpal, Meenal, Neha Mehta-Shah, Pooja Virmani, Patricia L. Myskowski, Alison Moskowitz, and Steven M. Horwitz. “Managing Patients with Cutaneous B-Cell and T-Cell Lymphomas Other Than Mycosis Fungoides.” Curr Hematol Malig Rep 11, no. 3 (June 2016): 224–33. https://doi.org/10.1007/s11899-016-0322-5.
       Full Text  Link to Item
    • Nghiem, B. T., M. Kheterpal, M. Dandekar, M. Chan, L. Lowe, and F. Wang. “Adult-onset eccrine angiomatous hamartoma: report of a rare entity with unusual histological features.” J Eur Acad Dermatol Venereol 28, no. 7 (July 2014): 981–83. https://doi.org/10.1111/jdv.12335.
       Full Text  Link to Item
    • Kheterpal, Meenal K., and Charles N. Ellis. “The impact of dermatology in premier medicine journals.” Skinmed 9, no. 5 (2011): 288–92.
       Link to Item
    • Gunawardena, Shanaka R., Brian L. Ruis, Julia A. Meyer, Meenal Kapoor, and Kathleen F. Conklin. “NOM1 Targets Protein Phosphatase I to the Nucleolus.” Journal of Biological Chemistry 283, no. 1 (January 2008): 398–404. https://doi.org/10.1074/jbc.m706708200.
       Full Text
    • Simmons, Heidi M., Brian L. Ruis, Meenal Kapoor, Andrew W. Hudacek, and Kathleen F. Conklin. “Identification of NOM1, a nucleolar, eIF4A binding protein encoded within the chromosome 7q36 breakpoint region targeted in cases of pediatric acute myeloid leukemia.” Gene 347, no. 1 (February 2005): 137–45. https://doi.org/10.1016/j.gene.2004.12.027.
       Full Text

  • Conference Papers

    • Farberg, Aaron S., Karl Lewis, Meenal Kheterpal, Kurt Gebauer, Alexander Guminski, Carmen Loquai, Nicholas Squittieri, and Ralf Gutzmer. “Time to onset of creatine kinase elevation in patients with advanced basal cell carcinoma receiving sonidegib 200 mg daily: Results from the 42-month BOLT study.” In Journal of the American Academy of Dermatology, 85:AB87–AB87, 2021.
       Link to Item
    • Loquai, C., R. Gutzmer, C. Robert, B. Dreno, A. Guminski, K. D. Lewis, M. Kheterpal, S. Martelli, R. Artnz, and N. Squittieri. “Time to Onset of major adverse clinical Events with Sonidegib and Vismodegib: a Post hoc Analysis.” In Journal Der Deutschen Dermatologischen Gesellschaft, 19:42–43, 2021.
       Link to Item
    • Patel, Akash D., Surya Ravichandran, and Meenal Kheterpal. “Efficacy of combined hedgehog inhibitors with and without adjunctive therapy in the treatment of locally advanced basal cell carcinoma.” In Journal of the American Academy of Dermatology, 85:AB103–AB103, 2021.
       Link to Item
    • Patel, Arsh, Meenal Kheterpal, Jane Kim, Jason Liss, Lauren Howard, and Sin-Ho Jung. “Combined modality therapies adjunctive to hedgehog inhibitors in the management of basal cell carcinoma: A systematic review and pooled-analysis.” In Journal of the American Academy of Dermatology, 85:AB81–AB81, 2021.
       Link to Item
    • Wong, Samantha, Christine Park, Meng Xia, William Ratliff, Ricardo Henao, and Meenal Kheterpal. “Use of convolutional neural networks in skin lesion analysis using real world image and nonimage data.” In Journal of the American Academy of Dermatology, 85:AB141–AB141, 2021.
       Link to Item
    • George, Ilena, Meenal Kheterpal, and Aaron Miller. “Lymphomatoid Papulosis in a 37-year-old Woman with Relapsing Multiple Sclerosis Treated with Dimethyl Fumarate.” In Neurology, Vol. 90, 2018.
       Link to Item
    • Geller, S., J. Dai, P. Myskowski, Y. H. Kim, A. Moskowitz, M. Pulitzer, R. Hoppe, S. M. Horwitz, and M. Kheterpal. “335 Utility of imaging in cutaneous marginal zone lymphoma.” In Journal of Investigative Dermatology, 137:S58–S58. Elsevier BV, 2017. https://doi.org/10.1016/j.jid.2017.02.352.
       Full Text
    • Kheterpal, Meenal, Shamir Geller, Julia Dai, Melissa Pulitzer, Patricia Myskowski, Alison J. Moskowitz, Jinah Kim, Richard T. Hoppe, Youn H. Kim, and Steven M. Horwitz. “Utility of Systemic Staging in Low Grade B-Cell Lymphomas Presenting in the Skin.” In Blood, Vol. 130, 2017.
       Link to Item
    • Mehta-Shah, Neha, Alison J. Moskowitz, Matthew A. Lunning, Peggy Lynch, Mark Scheuerman, Veenna Minnal, Natasha Galasso, et al. “A Phase Ib/IIa Trial of the Combination of Romidepsin, Lenalidomide and Carfilzomib in Patients with Relapsed/Refractory Lymphoma Shows Complete Responses in Relapsed and Refractory B-and T-Cell Lymphomas.” In Blood, Vol. 130, 2017.
       Link to Item
    • Moskowitz, Alison J., Raphael Koch, Neha Mehta-Shah, Patricia Myskowski, Meenal Kheterpal, Ahmet Dogan, Theresa Davey, et al. “In Vitro, In Vivo, and Parallel Phase I Evidence Support the Safety and Activity of Duvelisib, a PI3K-delta,gamma Inhibitor, in Combination with Romidepsin or Bortezomib in Relapsed/Refractory T-Cell Lymphoma.” In Blood, Vol. 130, 2017.
       Link to Item
    • Mehta-Shah, Neha, Alison J. Moskowitz, Matthew Lunning, Peggy Lynch, Mark Scheuerman, Anita Kumar, John F. Gerecitano, et al. “A Phase Ib/IIa Trial of the Combination of Romidepsin, Lenalidomide and Carfilzomib in Patients with Relapsed/Refractory Lymphoma Shows Complete Responses in Relapsed and Refractory T-Cell Lymphomas.” In Blood, 128:2991–2991. American Society of Hematology, 2016. https://doi.org/10.1182/blood.v128.22.2991.2991.
       Full Text
    • Majewksi, Sara, Meenal Kheterpal, Beatrice Nardone, Kimberly Sable, Dennis P. West, and Mario E. Lacouture. “First line biologic agent therapy for moderate-to-severe psoriasis in cancer survivors.” In Journal of the American Academy of Dermatology, 74:AB250–AB250, 2016.
       Link to Item

  • Preprints

    • Park, Christine, Hyeon Ki Jeong, Ricardo Henao, and Meenal Kheterpal. “Current Landscape of Generative Adversarial Networks for Facial Deidentification in Dermatology: Systematic Review and Evaluation (Preprint).” JMIR Publications Inc., December 8, 2021. https://doi.org/10.2196/preprints.35497.
       Full Text

Some information on this profile has been compiled automatically from Duke databases and external sources. (Our About page explains how this works.) If you see a problem with the information, please write to Scholars@Duke and let us know. We will reply promptly.